FDA

Project Livin’ Label is an educational initiative where using product labeling as a guide, the FDA’s Oncology Center of Excellence (OCE) will moderate the panel discussion – between a FDA reviewer, a clinical trial investigator, a patient who has used the therapy, and a representative from the company that developed the drug. Together, they delve into the journey of the oncology product from development to approval.